User login
Article Type
              
          Changed
              Thu, 08/26/2021 - 15:50
          Display Headline
              COVID-19 vaccines: New candidates & answers to commonly asked questions
          REFERENCES
- CDC. COVID-19 vaccination. Accessed February 22, 2021.
 - CDC. COVID data tracker. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
 - Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
 - CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.
 
Issue
              The Journal of Family Practice - 70(2)
          Page Number
              audio
          Sections
          
      REFERENCES
- CDC. COVID-19 vaccination. Accessed February 22, 2021.
 - CDC. COVID data tracker. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
 - Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
 - CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.
 
REFERENCES
- CDC. COVID-19 vaccination. Accessed February 22, 2021.
 - CDC. COVID data tracker. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
 - Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
 - Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
 - CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.
 
Issue
              The Journal of Family Practice - 70(2)
          Issue
              The Journal of Family Practice - 70(2)
          Page Number
              audio
          Page Number
              audio
          Article Type
              
          Display Headline
              COVID-19 vaccines: New candidates & answers to commonly asked questions
          Display Headline
              COVID-19 vaccines: New candidates & answers to commonly asked questions
          Sections
          
      Disallow All Ads
              
          Content Gating
              No Gating (article Unlocked/Free)
          Alternative CME
              
          Disqus Comments
              Default
          Consolidated Pubs: Do Not Show Source Publication Logo
              
          Use ProPublica
              
          Conference Recap Checkbox
              Not Conference Recap
          Clinical Edge
              
          Medscape Article
              
          Display survey writer
              
          Reuters content